✉news ScienceScience first seen 5 d ago, last 5 d ago, peak #25

Arndt Vogel presents Phase I update for BGB-B2033 in advanced liver cancer

Original: Arndt Vogel: Phase I Data Update for BGB-B2033 in Advanced HCC

Oncologist Arndt Vogel has shared an update on Phase I clinical trial data for BGB-B2033, an investigational drug being tested in patients with advanced hepatocellular carcinoma (HCC). The update, reported by oncology news outlet Oncodaily, offers new early-stage safety and efficacy findings for the compound. Early-phase results in liver cancer draw attention as treatment options for advanced disease remain limited.

Why now: Early-phase trial data in advanced hepatocellular carcinoma is closely followed by oncologists seeking new treatment options.

Arndt VogelBGB-B2033hepatocellular carcinomaOncodaily

Open on news →

Evidence

• Arndt Vogel: Phase I Data Update for BGB-B2033 in Advanced HCC · Oncodaily

API: https://socialmediatrends-api.osmike.com/v1/trends/3541718